{"id":87902,"date":"2026-02-15T12:34:44","date_gmt":"2026-02-15T09:34:44","guid":{"rendered":"https:\/\/www.egemtv.com\/?p=87902"},"modified":"2026-02-15T12:34:44","modified_gmt":"2026-02-15T09:34:44","slug":"uluslararasi-cocukluk-cagi-kanseri-gununde-umut-veren-veriler","status":"publish","type":"post","link":"https:\/\/www.egemtv.com\/?p=87902","title":{"rendered":"Uluslararas\u0131 \u00c7ocukluk \u00c7a\u011f\u0131 Kanseri G\u00fcn\u00fc\u2019nde umut veren veriler"},"content":{"rendered":"<p>\u00c7ocuk Onkoloji Uzman\u0131 Prof. Dr. Nur Olgun, \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinde elde edilen ba\u015far\u0131lar\u0131n umut verdi\u011fini s\u00f6yledi. Prof. Dr. Olgun, &#8220;2002-2024 y\u0131llar\u0131 aras\u0131nda kay\u0131t sistemine toplam 52 bin 907 hasta kaydedildi. Bu hastalarda 5 y\u0131ll\u0131k sa\u011fkal\u0131m oran\u0131n\u0131n y\u00fczde 70\u2019in \u00fczerinde olmas\u0131, \u00fclkemizde \u00e7ocuk onkolojisi alan\u0131nda ula\u015f\u0131lan seviyeyi a\u00e7\u0131k\u00e7a g\u00f6stermektedir. \u00c7ocuklar\u0131m\u0131z i\u00e7in umut var, bilim var, gelecek var&#8221; dedi.<br \/>\n<br \/>Ac\u0131badem Kent Hastanesi \u00c7ocuk Onkoloji B\u00f6l\u00fcm\u00fc Sorumlusu ve T\u00fcrk Pediatrik Onkoloji Grubu (TPOG) N\u00f6roblastom Protokolleri Koordinat\u00f6r\u00fc Prof. Dr. Nur Olgun, 15 \u015eubat Uluslararas\u0131 \u00c7ocukluk \u00c7a\u011f\u0131 Kanseri G\u00fcn\u00fc dolay\u0131s\u0131yla de\u011ferlendirmelerde bulundu. Prof. Dr. Olgun, bu g\u00fcn\u00fcn amac\u0131n\u0131 &#8220;\u00e7ocukluk \u00e7a\u011f\u0131nda g\u00f6r\u00fclen kanserlere dikkat \u00e7ekmek, erken tan\u0131n\u0131n \u00f6nemini vurgulamak ve bu zorlu s\u00fcre\u00e7te \u00e7ocuklar ile ailelerine destek olmak&#8221; olarak \u00f6zetledi.<br \/>\n<br \/>\u00c7ocukluk \u00e7a\u011f\u0131 kanserlerinin eri\u015fkin kanserlerinden farkl\u0131 \u00f6zellikler ta\u015f\u0131d\u0131\u011f\u0131na dikkat \u00e7eken Prof. Dr. Olgun, &#8220;\u00c7ocuklarda g\u00f6r\u00fclen kanserler biyolojik yap\u0131lar\u0131, seyirleri ve tedaviye verdikleri yan\u0131t a\u00e7\u0131s\u0131ndan eri\u015fkin kanserlerinden ayr\u0131l\u0131r. En s\u0131k l\u00f6semiler, beyin t\u00fcm\u00f6rleri, lenfomalar, n\u00f6roblastom, Wilms t\u00fcm\u00f6r\u00fc ve kemik t\u00fcm\u00f6rleri ile kar\u015f\u0131la\u015f\u0131yoruz. Sevindirici olan ise, g\u00fcn\u00fcm\u00fczde \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinin \u00f6nemli bir b\u00f6l\u00fcm\u00fcn\u00fcn tamamen tedavi edilebilir hale gelmi\u015f olmas\u0131d\u0131r&#8221; diye konu\u015ftu.<\/p>\n<p>2002 y\u0131l\u0131ndan bu yana kay\u0131t tutuluyor<br \/>\n<br \/>T\u00fcrkiye\u2019de \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerine y\u00f6nelik sistematik kay\u0131tlar\u0131n 2002 y\u0131l\u0131nda ba\u015flad\u0131\u011f\u0131n\u0131 hat\u0131rlatan Prof. Dr. Olgun, bu alandaki b\u00fcy\u00fck hasta serilerinin \u00fclkemiz i\u00e7in \u00e7ok de\u011ferli oldu\u011funu vurgulayarak, &#8220;2002-2024 y\u0131llar\u0131 aras\u0131nda \u00e7ocukluk \u00e7a\u011f\u0131 kanserleri kay\u0131t sistemine toplam 52 bin 907 hasta kaydedilmi\u015ftir. Bu hastalarda 5 y\u0131ll\u0131k sa\u011fkal\u0131m oran\u0131n\u0131n y\u00fczde 70\u2019in \u00fczerinde olmas\u0131, \u00fclkemizde \u00e7ocuk onkolojisi alan\u0131nda ula\u015f\u0131lan seviyeyi ve uygulanan tedavilerin ba\u015far\u0131s\u0131n\u0131 a\u00e7\u0131k\u00e7a g\u00f6stermektedir&#8221; dedi.<br \/>\n<br \/>Bu verilerin, erken tan\u0131, standartla\u015ft\u0131r\u0131lm\u0131\u015f ulusal protokoller ve multidisipliner yakla\u015f\u0131m\u0131n \u00f6nemini ortaya koydu\u011funu belirten Olgun, kay\u0131t sistemlerinin g\u00fc\u00e7lendirilmesinin gelecekteki iyile\u015ftirmeler i\u00e7in kritik oldu\u011funu ifade etti.<\/p>\n<p>Belirtiler konusunda dikkatli olunmal\u0131<br \/>\n<br \/>Erken tan\u0131n\u0131n hayat kurtar\u0131c\u0131 rol\u00fcne vurgu yapan Olgun, ailelerin baz\u0131 belirtiler konusunda dikkatli olmas\u0131 gerekti\u011fini belirterek \u015funlar\u0131 s\u00f6yledi:<br \/>\n<br \/>&#8220;Uzam\u0131\u015f ate\u015f, nedeni a\u00e7\u0131klanamayan kilo kayb\u0131, solukluk, morarma, kemik a\u011fr\u0131lar\u0131, v\u00fccutta \u015fi\u015flikler, halsizlik ve i\u015ftahs\u0131zl\u0131k gibi bulgular \u00f6nemlidir. Bu belirtiler her zaman kanser anlam\u0131na gelmez ancak uzun s\u00fcr\u00fcyorsa mutlaka hekime ba\u015fvurulmal\u0131d\u0131r. Erken tan\u0131, tedavi ba\u015far\u0131s\u0131n\u0131 do\u011frudan etkileyen en kritik fakt\u00f6rd\u00fcr.&#8221;<br \/>\n<br \/>Son y\u0131llarda \u00e7ocuk onkolojisinde \u00f6nemli geli\u015fmeler ya\u015fand\u0131\u011f\u0131n\u0131 ifade eden Prof. Dr. Olgun, kemoterapi, cerrahi ve radyoterapinin yan\u0131 s\u0131ra k\u00f6k h\u00fccre nakli, hedefe y\u00f6nelik tedaviler ve imm\u00fcnoterapilerin giderek daha fazla kullan\u0131ld\u0131\u011f\u0131n\u0131 s\u00f6yledi. Ayr\u0131ca genetik ve molek\u00fcler d\u00fczeyde yap\u0131lan \u00e7al\u0131\u015fmalar\u0131n ki\u015fiye \u00f6zel tedavi yakla\u015f\u0131mlar\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7t\u0131\u011f\u0131n\u0131 belirtti.<br \/>\n<br \/>Bu ilerlemelerin en \u00e7arp\u0131c\u0131 \u00f6rneklerinden birinin ileri evre n\u00f6roblastom hastalar\u0131nda g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc vurgulayan Olgun, \u015fu bilgiyi payla\u015ft\u0131:<br \/>\n<br \/>&#8220;1992 y\u0131l\u0131nda y\u00fcksek risk n\u00f6roblastom hastalar\u0131nda sa\u011fkal\u0131m oran\u0131 yaln\u0131zca y\u00fczde 6 iken, bu oran TPOG NB 2003, 2009 ve 2020 protokolleri ile yakla\u015f\u0131k y\u00fczde 65\u2019e y\u00fckselmi\u015ftir. Bu \u00f6nemli art\u0131\u015f; risk gruplamas\u0131nda molek\u00fcler ve sitogenetik fakt\u00f6rlerin dikkate al\u0131nmas\u0131, hedef tedaviler ve imm\u00fcnoterapi uygulamalar\u0131 gibi yeni tedavi stratejileri sayesinde m\u00fcmk\u00fcn olmu\u015ftur.&#8221;<br \/>\n<br \/>Olgun, bu geli\u015fmelerin b\u00fcy\u00fck \u00f6l\u00e7\u00fcde D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc ve di\u011fer uluslararas\u0131 kurulu\u015flar\u0131n destekledi\u011fi k\u00fcresel i\u015f birlikleriyle daha da h\u0131z kazand\u0131\u011f\u0131n\u0131 s\u00f6zlerine ekledi.<br \/>\n<br \/>Kanserle m\u00fccadelenin yaln\u0131zca t\u0131bbi bir s\u00fcre\u00e7 olmad\u0131\u011f\u0131n\u0131 ifade eden Olgun, &#8220;\u00c7ocuklar\u0131n e\u011fitimden ve sosyal hayattan kopmamas\u0131, oyun oynayabilmesi ve ya\u015f\u0131tlar\u0131yla ileti\u015fim kurabilmesi \u00e7ok \u00f6nemlidir. Ayn\u0131 \u015fekilde ailelerin de psikolojik ve sosyal destek alabilmesi, tedavi s\u00fcrecini olumlu y\u00f6nde etkiler. Bu m\u00fccadele bir ekip i\u015fidir&#8221; dedi.<br \/>\n<br \/>Uluslararas\u0131 \u00c7ocukluk \u00c7a\u011f\u0131 Kanseri G\u00fcn\u00fc\u2019n\u00fcn topluma \u00f6nemli bir sorumluluk hat\u0131rlatt\u0131\u011f\u0131n\u0131 belirten Prof. Dr. Nur Olgun, s\u00f6zlerini \u015f\u00f6yle tamamlad\u0131:<br \/>\n<br \/>&#8220;Her \u00e7ocuk sa\u011fl\u0131kl\u0131 bir gelece\u011fi hak eder. Fark\u0131ndal\u0131k artt\u0131k\u00e7a erken tan\u0131 oranlar\u0131 y\u00fckselir ve daha fazla \u00e7ocuk hayata tutunur. Bug\u00fcn at\u0131lan her ad\u0131m, yar\u0131n daha fazla \u00e7ocu\u011fun g\u00fcl\u00fcmsemesi demektir. \u00c7ocuklar\u0131m\u0131z i\u00e7in umut var, bilim var ve gelecek var.&#8221;<br \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c7ocuk Onkoloji Uzman\u0131 Prof. Dr. Nur Olgun, \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinde elde edilen ba\u015far\u0131lar\u0131n umut verdi\u011fini s\u00f6yledi. Prof. Dr. Olgun, &#8220;2002-2024 y\u0131llar\u0131 aras\u0131nda kay\u0131t sistemine toplam 52 bin 907 hasta kaydedildi. Bu hastalarda 5 y\u0131ll\u0131k sa\u011fkal\u0131m oran\u0131n\u0131n y\u00fczde 70\u2019in \u00fczerinde olmas\u0131, \u00fclkemizde \u00e7ocuk onkolojisi alan\u0131nda ula\u015f\u0131lan seviyeyi a\u00e7\u0131k\u00e7a g\u00f6stermektedir. \u00c7ocuklar\u0131m\u0131z i\u00e7in umut var, bilim var, gelecek&#8230;<\/p>\n","protected":false},"author":1,"featured_media":87903,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-87902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/87902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=87902"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/87902\/revisions"}],"predecessor-version":[{"id":87904,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/87902\/revisions\/87904"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/87903"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=87902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=87902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=87902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}